Article | 8/6/2025

TAVR Patients Get Younger as Technology Ages

MedTech Strategist

By Mariel Young, PhD, Vikki Leung, and Bridget D’Angelo

Transcatheter aortic valve replacement (TAVR) has been one of the fastest growing medtech markets for the last decade, and as it begins to mature, predictions vary as to the remaining potential for penetration into total aortic valve replacement (AVR) procedures. With frequent changes in recommendations and guidelines, real-world data can help us understand shifts in the age demographics of patients who undergo TAVR versus surgical aortic valve replacement (SAVR) and how these trends might point to expected changes in future market dynamics.

Read here.